Returns
-5.12%
Loading chart...
Fundamentals
Large Cap
Financial - Banking
Market Cap (Cr)
20381.78
Earning Per Share
8.88
Dividend Yield
-%
P/E Ratio
-
P/B Ratio
7.21
Debt to Equity
0.89
Performance
min-value
max-value
Open
56,601.30
52-wk High
75,250.00
High
56,601.30
52-wk Low
75,250.00
Low
56,601.30
Band
75,250.00
Lower Circuit
56,601.30
Upper Circuit
75,250.00
Volume
56,601.30
VWAP
75,250.00
52 Week Performance
min-value
max-value

5.34% down side
up side5.34%

About the company
Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay. Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001. Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad
range of pharmaceutical products across several major therapeutic areas. They are a research and development driven company with a differentiated product portfolio that includes orals, injectables and biotherapeutics, which has enabled to reach target markets across over 70 countries, with a strong presence in India, Europe and Canada. In India, they are present across acute and chronic therapeutic areas, and their key therapeutic areas include gynecology, cardiovascular, vitamins, minerals and nutrients, human immunodeficiency virus antivirals, blood-related and oncology/anti-neoplastics.